Latest Feature

Sequent Medical CEO Wilder bets on braids

Sequent Medical CEO Tom Wilder tells MassDevice.com why his company's MicroBraid technology is a key differentiator in its Web device for treating brain aneurysms and, potentially, other conditions.

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pus

In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.

Medicare: Medical device companies paid out $200m to physicians last year

Medical device companies' aggregate spend on payment and other gifts to physicians was at least $200 million last year, according to the U.S. Health & Human Services Dept., but critics (and the agency itself) flag widespread problems with the Open Payments database.

Checking on Orange County's medtech climate with OCTANe's Matthew Jenusaitis

Orange County, Calif.'s most-connected man, OCTANe's Matthew Jenusaitis talks to MassDevice.com about OCTANe's 2014 Medical Device Investor Forum.

What's behind the slump in early-stage medtech investment?

Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

HCA hospitals halt use of uterine fibroid surgical tool

November 25, 2014 by MassDevice

HCA Holdings halts the use of laparoscopic power morcellators in uterine fibroid surgeries in all 278 of its facilities, after the FDA raises the warning level on the cancer risk associated with the devices.

HCA hospitals halt use of uterine fibroid surgical tool

(Reuters) — HCA Holdings (NYSE:HCA), the largest for-profit U.S. hospital operator, said a procedure for removing uterine fibroids that's been linked to the spread of cancer will no longer be performed at its facilities.

Vascular Solutions wins FDA nod for Gel-Block embolization foam

November 25, 2014 by Mark Hollmer

Vascular Solutions says the FDA granted 510(k) clearance for its Gel-Block embolization foam.

Vascular Solutions wins FDA nod for embolization foam

MassDevice.com +3 | The top 3 medtech stories for November 25, 2014

November 25, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Medtronic expects to free up to $4B after IRS beef is settled

November 25, 2014 by Brad Perriello

Medtronic says it expects to repatriate as much as $4 billion in cash after it resolves a dispute with the IRS involving its Puerto Rico subsidiary.

Medtronic expects to free up to $4B after IRS beef is settled

Medtronic (NYSE:MDT) said today that it expects to land a substantial windfall once it resolves a dispute with the IRS over the next "couple of years."

Plaintiffs in Bard's pelvic mesh MDL want cases tried together

November 25, 2014 by Brad Perriello

The plaintiffs in 185 lawsuits filed against C.R. Bard over its Avaulta pelvic mesh as part of a multi-district litigation want their cases tried together.

Plaintiffs in Bard's pelvic mesh MDL want cases tried together

Medical device tax pushes B. Braun to spike HQ expansion plans

November 25, 2014 by Brad Perriello

B. Braun spikes its plan to expand its headquarters to absorb the annual $13 million hit it takes from the medical device tax, CEO Caroll Neubauer tells MassDevice.com.

Medical device tax pushes B. Braun to spike HQ expansion plans

B. Braun Medical is spiking its plan to expand its Pennsylvania headquarters due to the medical device tax, CEO Caroll Neubauer told MassDevice.com last week.

BD plans to use more cash, less debt for $12B CareFusion buy

November 25, 2014 by Brad Perriello

Becton Dickinson plans to cut the debt load from its $12 billion acquisition of CareFusion by some $1.4 billion after realizing it has more cash available that it thought.

BD plans to use more cash, less debt for $12B CareFusion buy

The importance of being scrappy: Tips from med tech entrepreneur Amar Sawhney

November 25, 2014 by MassDevice

Ocular Therapeutix CEO Amar Sawhney talks to S2N Health about how a little bit of scrap can lead to a lot of wins for medtech startups

By Amy Siegel, S2N Health

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp